As of 2026-03-20, the Relative Valuation of Krystal Biotech Inc (KRYS) is 175.37 USD. This relative valuation is based on P/E multiples. With the latest stock price at 258.00 USD, the upside of Krystal Biotech Inc based on Relative Valuation is -32.0%.
The range of the Relative Valuation is 140.05 - 216.39 USD.
| Range | Selected | |
| Trailing P/E multiples | 23.7x - 30.9x | 27.0x |
| Forward P/E multiples | 21.8x - 30.8x | 25.2x |
| Fair Price | 140.05 - 216.39 | 175.37 |
| Upside | -45.7% - -16.1% | -32.0% |
| Date | P/E |
| 2026-03-19 | 36.82 |
| 2026-03-18 | 35.79 |
| 2026-03-17 | 36.58 |
| 2026-03-16 | 35.70 |
| 2026-03-13 | 35.28 |
| 2026-03-12 | 35.86 |
| 2026-03-11 | 36.39 |
| 2026-03-10 | 37.26 |
| 2026-03-09 | 36.91 |
| 2026-03-06 | 36.20 |
| 2026-03-05 | 37.15 |
| 2026-03-04 | 37.82 |
| 2026-03-03 | 37.65 |
| 2026-03-02 | 36.93 |
| 2026-02-27 | 39.33 |
| 2026-02-26 | 39.44 |
| 2026-02-25 | 38.89 |
| 2026-02-24 | 38.09 |
| 2026-02-23 | 39.18 |
| 2026-02-20 | 37.36 |
| 2026-02-19 | 37.48 |
| 2026-02-18 | 40.43 |
| 2026-02-17 | 41.08 |
| 2026-02-13 | 39.45 |
| 2026-02-12 | 38.57 |
| 2026-02-11 | 38.91 |
| 2026-02-10 | 38.63 |
| 2026-02-09 | 38.90 |
| 2026-02-06 | 38.92 |
| 2026-02-05 | 38.19 |
| 2026-02-04 | 38.41 |
| 2026-02-03 | 39.90 |
| 2026-02-02 | 40.28 |
| 2026-01-30 | 39.85 |
| 2026-01-29 | 39.86 |
| 2026-01-28 | 38.95 |
| 2026-01-27 | 39.58 |
| 2026-01-26 | 39.78 |
| 2026-01-23 | 40.18 |
| 2026-01-22 | 41.26 |
| 2026-01-21 | 40.81 |
| 2026-01-20 | 39.22 |
| 2026-01-16 | 40.68 |
| 2026-01-15 | 40.24 |
| 2026-01-14 | 41.64 |
| 2026-01-13 | 41.66 |
| 2026-01-12 | 38.83 |
| 2026-01-09 | 37.30 |
| 2026-01-08 | 35.52 |
| 2026-01-07 | 35.16 |